Aim: In recent years, we have seen a considerable increase in the relevance of nanostructures for the safe delivery of therapeutic agents and their capacity as an immunomodulatory tool.
Materials And Methods: Potential clinical applications related to their unique structural properties have been described in the evolving landscape of immunotherapy.
Results: This review briefly summarizes the evidence for the role of nanoparticles in regulating the immune response.